Chicago, IL – January 27, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...

Abbott Laboratories (NYSE ... Now in retirement, our only income is Social Security, a small pension and required minimum distributions (RMDs) from our SEP IRAs. Our portfolio is under seven ...

Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...

The global heart valve frame market is poised for significant growth over the coming years, driven by factors such as increasing prevalence of cardiovascular ...

Abbott Laboratories’ ABT growth in the fourth ... This could also result in broader economic impacts and security concerns, affecting the company’s business in the upcoming months.

These players, together, could offer your portfolio growth and the security of steady earnings ... Fool has positions in and recommends Abbott Laboratories, CRISPR Therapeutics, Intuitive Surgical ...

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include ...

The peers of Abbott India Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd ... recommendation for the purchase or sale of any security or investment. You are advised to exercise ...